Latest news
On this page you can read about the latest news about Dermicus – our teledermatology platform for digital diagnostic support. A faster and more secure diagnosis of skin lesions and wounds.
EU conference on cancer in Stockholm
8 February 2023: Dermicus and Region Stockholm – On February 1st Swedish healthcare was highlighted by Swecare in an exhibition at Conference on Cancer under the Swedish EU Presidency.
Read more
Dermicus top 10
16 January 2023: Dermicus (Gnosco) was ranked top 10 in the category “fast growth” among digital health firms in Sweden.
Read more
Gnosco and Barco's dermatology operations merge
12 September 2022: Gnosco merges with Demetra, the Belgian dermatology business of Barco, strengthening the further development of Dermicus.
Read more
Demetra skin imaging partnership with MediPortal
23 June 2022: Barco Demetra skin imaging solution and MediPortal, the belgian-based healthcare software developer, announce new partnership.
Read more
Dermicus at more than 100 health centers
22 June 2022: Fewer unnecessary surgeries for suspicions skin lesions with the help of Dermicus in Region Stockholm Sweden.
Read more
Demetra grow in practices in the US
21 June 2022: Demetra skin imaging solution is leveraging technology to improve communication and efficiency in dermatology, first launched in the US in 2021.
Read more
Vinnova funding on AI and skin cancer
9 June 2022: Gnosco, Skåne University Hospital and Chalmers Industriteknik have been granted funding by the Swelife and Medtech4Health collaboration announcement.
Read more
WAHSN Dermicus final evaluation report skin cancer
23 February 2022: An independent report by Wessex AHSN of the Dermicus platform states that teledermatology can dramatically improve the speed to diagnose skin cancer.
Read more
A part of the Swedish way
4 February 2022: Implementing Dermicus for the diagnosis of skin cancer in Skåne and Stockholm regions is highlighted in Swecare's latest online brochure.
Read more
ISO 27001 certification
25 September 2021: Gnosco has achieved ISO 27001 certification, the international standard for information security.
Read more
New AI supported features
23 September 2021: Gnosco continues to invest in AI supported features for image quality assurance in teledermatology, such as Dermicus AI Focus and Dermicus AI Light.
Read more
Min Doktor has implemented Dermicus
2 July 2021: The Swedish healthcare company Min Doktor’s care and vaccination clinics has during May and June implemented Dermicus – Gnosco's teledermatology platform for the management of patients with skin changes at more than 30 clinics around Sweden.
Read more
Gnosco and Min Doktor initiates a collaboration
9 April 2021: During April three of the Swedish healthcare company Min Doktor's care and vaccination clinics will be first to document skin changes with Dermicus.
Read more
Dermicus NHS team finalists addressing skin cancer in the HSJ Awards
24 March 2021: The Isle of Wight is first to implement the Dermicus teledermatology platform for early diagnosis of skin cancer. Following a successful implementation, the team was shortlisted for the NHS 2020 HSJ Awards – Primary Care Innovation of the Year.
Read morePartnership with Modernizing Medicine
23 March 2021: Demetra skin imaging system is now interfaced with Modernizing Medicine’s electronic medical record (EMR).
Read more
Delivery of community-based dermatology
19 March 2021: Dr. med. Hans-Werner Owzarski Germany about harnessing new technology.
Read more
The IOW NHS in UK and Region Stockholm Sweden first to implement Dermicus
27 January 2021: Gnosco has won a tender for the supply of Dermicus in Region Stockholm Sweden. GPs, for all 220 health centres in the region, will use the teledermatology platform.
Read more
Implementation of Dermicus Wound EWMA 2020
19 October 2020: RiksSår in Sweden has actively participated in validations of Dermicus Wound that have been tested by care providers connected to the national quality registry. Here is a summary of some results from the implementation and testing of Dermicus in 2020.
Read more
Dermicus passes NHS Digital assurance to help with coronavirus
17 October 2020: In response to the coronavirus emergency, Dermicus have been through accelerated assurance from NHS Digital, which covers key characteristics such as Clinical Safety and Information Governance.
Read more
The use of Dermicus during COVID-19
14 July 2020: Dr Amy Poyner, a GP on the Isle of Wight, highlights how using teledermatology has not only improved the process for skin cancer diagnosis, but ensured referrals continue as normal during the COVID-19 pandemic.
Read more
Skin Parameter Maps
5 February 2020: Multispectral dermoscopy value in skin cancer diagnosis. The technology allows to see more detail of skin lesions and has proven its value in the diagnosis of skin cancer.
Read more
Several projects and agreements in UK during spring 2019
12 August 2019: The UK’s leading GP publication announces Dermicus teledermatology go live in the NHS, and Dermicus Teledermatology platform is now live in the Digital Marketplace catalogue.
Read more
